Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of LINCOLN PHAR. For more details, see the LINCOLN PHAR quarterly results and LINCOLN PHAR share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.3 |
No. of shares | m | 20.03 |
1 Week | % | -5.7 |
1 Month | % | 0.3 |
1 Year | % | 42.8 |
52 week H/L | Rs | 754.3/365.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
LINCOLN PHAR EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 314 | 220 | 283 | 415 | 380 | |
Low | Rs | 157 | 86 | 121 | 221 | 255 | |
Sales per share (Unadj.) | Rs | 183.1 | 193.2 | 211.8 | 235.7 | 254.8 | |
Earnings per share (Unadj.) | Rs | 24.4 | 25.7 | 31.1 | 34.6 | 36.4 | |
Diluted earnings per share | Rs | 24.3 | 25.7 | 31.1 | 34.6 | 36.4 | |
Cash flow per share (Unadj.) | Rs | 27.7 | 29.4 | 34.9 | 38.7 | 41.0 | |
Dividends per share (Unadj.) | Rs | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | |
Adj. dividends per share | Rs | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | |
Avg Dividend yield | % | 0.6 | 1.0 | 0.7 | 0.5 | 0.5 | |
Book value per share (Unadj.) | Rs | 134.7 | 156.5 | 182.9 | 216.1 | 250.9 | |
Adj. book value per share | Rs | 134.5 | 156.3 | 182.9 | 216.1 | 250.9 | |
Shares outstanding (eoy) | m | 20.00 | 20.00 | 20.03 | 20.03 | 20.03 | |
Price / Sales ratio | x | 1.3 | 0.8 | 1.0 | 1.3 | 1.2 | |
Avg P/E ratio | x | 9.7 | 5.9 | 6.5 | 9.2 | 8.7 | |
P/CF ratio (eoy) | x | 8.5 | 5.2 | 5.8 | 8.2 | 7.7 | |
Price / Book Value ratio | x | 1.7 | 1.0 | 1.1 | 1.5 | 1.3 | |
Dividend payout | % | 6.2 | 5.8 | 4.8 | 4.3 | 4.1 | |
Avg Mkt Cap | Rs m | 4,714 | 3,055 | 4,044 | 6,370 | 6,358 | |
Total wages/salary | Rs m | 519 | 587 | 633 | 797 | 932 |
LINCOLN PHAR INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,661 | 3,865 | 4,242 | 4,721 | 5,103 | |
Other income | Rs m | 56 | 110 | 57 | 100 | 225 | |
Total revenues | Rs m | 3,718 | 3,975 | 4,298 | 4,821 | 5,328 | |
Gross profit | Rs m | 672 | 655 | 872 | 955 | 892 | |
Depreciation | Rs m | 67 | 73 | 76 | 81 | 92 | |
Interest | Rs m | 40 | 20 | 16 | 15 | 20 | |
Profit before tax | Rs m | 622 | 672 | 837 | 959 | 1,005 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 135 | 158 | 215 | 266 | 276 | |
Profit after tax | Rs m | 487 | 515 | 623 | 694 | 729 | |
Gross profit margin | % | 18.4 | 17.0 | 20.6 | 20.2 | 17.5 | |
Effective tax rate | % | 21.6 | 23.4 | 25.6 | 27.7 | 27.4 | |
Net profit margin | % | 13.3 | 13.3 | 14.7 | 14.7 | 14.3 |
LINCOLN PHAR BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,391 | 2,627 | 3,277 | 3,731 | 3,911 | |
Current liabilities | Rs m | 1,004 | 803 | 948 | 1,107 | 962 | |
Net working cap to sales | % | 37.9 | 47.2 | 54.9 | 55.6 | 57.8 | |
Current ratio | x | 2.4 | 3.3 | 3.5 | 3.4 | 4.1 | |
Inventory Days | Days | 54 | 81 | 110 | 101 | 128 | |
Debtors Days | Days | 1,221 | 957 | 975 | 896 | 975 | |
Net fixed assets | Rs m | 1,594 | 1,739 | 1,596 | 1,815 | 2,454 | |
Share capital | Rs m | 200 | 200 | 200 | 200 | 200 | |
"Free" reserves | Rs m | 2,493 | 2,931 | 3,464 | 4,128 | 4,824 | |
Net worth | Rs m | 2,693 | 3,131 | 3,664 | 4,329 | 5,025 | |
Long term debt | Rs m | 17 | 8 | 1 | 0 | 0 | |
Total assets | Rs m | 3,985 | 4,366 | 4,873 | 5,546 | 6,365 | |
Interest coverage | x | 16.6 | 34.3 | 54.6 | 67.1 | 50.5 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.9 | 0.9 | 0.9 | 0.8 | |
Return on assets | % | 13.2 | 12.2 | 13.1 | 12.8 | 11.8 | |
Return on equity | % | 18.1 | 16.4 | 17.0 | 16.0 | 14.5 | |
Return on capital | % | 24.4 | 22.1 | 23.3 | 22.5 | 20.4 | |
Exports to sales | % | 53.9 | 56.1 | 60.7 | 57.1 | 57.4 | |
Imports to sales | % | 1.4 | 0.9 | 1.3 | 2.6 | 2.0 | |
Exports (fob) | Rs m | 1,974 | 2,170 | 2,574 | 2,695 | 2,931 | |
Imports (cif) | Rs m | 51 | 36 | 54 | 122 | 100 | |
Fx inflow | Rs m | 1,974 | 2,170 | 2,574 | 2,695 | 2,931 | |
Fx outflow | Rs m | 51 | 36 | 54 | 122 | 100 | |
Net fx | Rs m | 1,924 | 2,134 | 2,519 | 2,572 | 2,831 |
LINCOLN PHAR CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 528 | 754 | 693 | 761 | 393 | |
From Investments | Rs m | -182 | -309 | -642 | -781 | -366 | |
From Financial Activity | Rs m | -358 | -378 | -57 | -26 | -45 | |
Net Cashflow | Rs m | -11 | 68 | -7 | -45 | -19 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Kishor M Shah | COMP SEC: Niren Atinbhai Desai | YEAR OF INC: 1995 | BSE CODE: 531633 | FV (Rs): 10 | DIV YIELD (%): 0.3 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare LINCOLN PHAR With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.